Smith & Nephew (SNN) Change in Cash (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Change in Cash of $250.0 million for Q4 2024, up 261.29% year-on-year from $69.2 million in Q1 2024, and up 261.29% on a QoQ basis from -$155.0 million in Q4 2023.
Smith & Nephew (SNN) Change in Cash (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Change in Cash for 16 consecutive years, with $250.0 million the latest figure, recorded in Q4 2024.
- Quarterly Change in Cash rose 261.29% year-over-year to $250.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.0 billion (up 14.61% YoY) and the FY2025 annual result came in at -$76.0 million, down 122.89% from the prior year.
- Change in Cash grew to $250.0 million in Q4 2024 per SNN's latest filing, from -$155.0 million in the prior quarter.
- Over the last five years, Change in Cash for SNN reached as high as $250.0 million in Q4 2024 and fell as low as -$765.0 million in Q4 2022.
- A 5-year average of -$193.6 million and a median of -$155.0 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash tumbled 613.89% — and 2024, when it jumped 261.29%.
- Year by year, Change in Cash stood at $72.0 million in 2020, then slumped by 613.89% to -$370.0 million in 2021, then slumped by 106.76% to -$765.0 million in 2022, then jumped by 79.74% to -$155.0 million in 2023, then soared by 261.29% to $250.0 million in 2024.
- According to Business Quant data, Change in Cash over the past three periods registered $250.0 million, -$155.0 million, and -$765.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.23 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -282.15 Mn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 250.00 Mn |
| Dec 31, 2023 | -155.00 Mn |
| Dec 31, 2022 | -765.00 Mn |
| Dec 31, 2021 | -370.00 Mn |
| Dec 31, 2020 | 72.00 Mn |
| Dec 31, 2019 | -211.00 Mn |
| Dec 31, 2018 | -71.00 Mn |
| Dec 31, 2017 | 4.00 Mn |
| Dec 31, 2016 | -63.00 Mn |
| Dec 31, 2015 | -25.00 Mn |
| Dec 31, 2014 | -54.00 Mn |
| Sep 30, 2014 | -21.00 Mn |
| Mar 31, 2014 | -39.00 Mn |
| Dec 31, 2013 | -54.00 Mn |
| Mar 31, 2013 | 10.00 Mn |
| Dec 31, 2012 | 65.00 Mn |
| Jun 30, 2012 | 287.00 Mn |
| Mar 31, 2012 | -251.00 Mn |
| Dec 31, 2011 | -106.00 Mn |
| Sep 30, 2011 | 61.00 Mn |